ACCORD: Insulin dose not implicated in excess CV deathsJune 26, 2013DiabetesLipid DisordersCAD & Atherosclerosis
FDA panels revisit rosiglitazone's cardiovascular safety June 13, 2013Lipid DisordersAcute Coronary SyndromesCAD & AtherosclerosisDiabetes
Medicare uses more brand-name drugs than does VAJune 11, 2013DiabetesLipid DisordersBusiness of Medicine
FDA panel supports easing rosiglitazone restrictionsJune 7, 2013CAD & AtherosclerosisLipid DisordersDiabetes
FDA panel starts review of rosiglitazone CV data June 6, 2013Acute Coronary SyndromesCAD & AtherosclerosisLipid DisordersDiabetes
Gastric bypass helps poorly controlled type 2 diabetesJune 4, 2013CAD & AtherosclerosisLipid DisordersDiabetes
Type 2 diabetics often harbor undiagnosed heart failureMay 20, 2013Lipid DisordersHeart FailureDiabetes
DEA scheduling brings weight-loss drug closer to marketMay 8, 2013CAD & AtherosclerosisHeart FailureDiabetesLipid Disorders
Six questions flag risk for cardiovascular hospitalizationMay 1, 2013Acute Coronary SyndromesHypertensionDiabetes
